SmartPharm Therapeutics, now a subsidiary of Sorrento Therapeutics, is a gene therapy company applying the next generation of non-viral DNA and RNA technologies to treat serious human diseases. Founded with the vision of producing “Biologics from Within,” SmartPharm is focused on bringing together unique technology and developmental capabilities for the treatment of rare diseases including lysosomal storage disorders.
SmartPharm Therapeutics is a second-generation gene-encoded therapeutics company that has benefited from the first decades of learning in gene therapy development to produce an evolved therapeutic platform. We integrate these insights with key technologies and engineering capabilities to enable us to produce optimal gene-encoded therapeutics for patients.
Company Details
- Founded
- -
- Address
- Cambridge, Massachusetts 02142, Us
- Phone
- +1.857.327.8740
- in****@****mtx.com
- Industry
- Biotechnology
- Website
- smartpharmtx.com
- HQ
- Cambridge, Massachusetts
Smartpharm Therapeutics, Inc. Questions
Smartpharm Therapeutics, Inc.'s helpline number is +1.857.327.8740
Smartpharm Therapeutics, Inc.'s website is smartpharmtx.com
Smartpharm Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/smartpharmtx
Smartpharm Therapeutics, Inc.'s industry is
Biotechnology
Smartpharm Therapeutics, Inc.'s top competitors are
Vigeo Therapeutics,
Empress Therapeutics,
Atalanta Therapeutics,
Tevard Biosciences,
Alcyone Therapeutics Inc.,
Diagonal Therapeutics,
Modalis Therapeutics,
Zata Pharmaceuticals, Inc.,
Exegenesis Bio,
Remedium Bio.
Smartpharm Therapeutics, Inc.'s support email address is info@smartpharmtx.com
Smartpharm Therapeutics, Inc.'s categories are Biotechnology
Smartpharm Therapeutics, Inc.'s founding year is 2017
